Boryung Future Growth

Future criteria checks 4/6

Boryung is forecast to grow earnings and revenue by 31.8% and 13.7% per annum respectively. EPS is expected to grow by 30.1% per annum. Return on equity is forecast to be 12.4% in 3 years.

Key information

31.8%

Earnings growth rate

30.1%

EPS growth rate

Pharmaceuticals earnings growth	33.8%
Revenue growth rate	13.7%
Future return on equity	12.4%
Analyst coverage	Low
Last updated	11 Mar 2024

Recent future growth updates

Recent updates

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 09

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Jan 25

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Dec 23

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Dec 08

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Nov 23

Earnings and Revenue Growth Forecasts

KOSE:A003850 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	1,137,133	79,567	79,500	94,500	3
12/31/2024	1,050,400	66,050	53,300	68,250	2
12/31/2023	859,626	40,203	19,169	42,224	N/A
9/30/2023	829,854	28,267	-120,022	-3,357	N/A
6/30/2023	819,463	38,284	-75,467	43,689	N/A
3/31/2023	785,679	42,063	-94,393	24,794	N/A
12/31/2022	760,476	41,894	-95,181	27,814	N/A
9/30/2022	724,659	53,911	2,909	66,442	N/A
6/30/2022	694,170	52,524	-37,854	22,893	N/A
3/31/2022	661,948	34,380	-24,301	37,032	N/A
12/31/2021	627,279	43,044	957	60,167	N/A
9/30/2021	600,008	41,823	31,493	51,816	N/A
6/30/2021	587,350	28,892	-1,699	56,164	N/A
3/31/2021	571,594	38,370	4,515	58,667	N/A
12/31/2020	561,867	26,856	-10,655	44,741	N/A
9/30/2020	562,433	27,744	-7,870	46,515	N/A
6/30/2020	546,974	27,969	25,017	46,561	N/A
3/31/2020	539,742	31,678	9,933	35,068	N/A
12/31/2019	524,269	32,222	-20,246	46,999	N/A
9/30/2019	498,006	32,950	-31,145	57,203	N/A
6/30/2019	480,242	29,886	-54,429	45,294	N/A
3/31/2019	467,445	22,830	-55,631	47,848	N/A
12/31/2018	460,402	20,307	-17,507	38,914	N/A
9/30/2018	441,580	64,630	-45,289	24,718	N/A
6/30/2018	440,087	62,855	-36,896	26,833	N/A
3/31/2018	434,565	60,451	-73,861	-12,386	N/A
12/31/2017	422,721	56,699	-90,144	-24,614	N/A
9/30/2017	426,554	-3,202	N/A	-31,392	N/A
6/30/2017	423,777	-2,977	N/A	-33,281	N/A
3/31/2017	420,133	5,020	N/A	402	N/A
12/31/2016	409,140	5,614	N/A	9,363	N/A
9/30/2013	317,657	12,366	N/A	31,456	N/A
6/30/2013	309,375	15,569	N/A	25,331	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A003850's forecast earnings growth (31.8% per year) is above the savings rate (2.5%).

Earnings vs Market: A003850's earnings (31.8% per year) are forecast to grow faster than the KR market (28.4% per year).

High Growth Earnings: A003850's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A003850's revenue (13.7% per year) is forecast to grow faster than the KR market (9.1% per year).

High Growth Revenue: A003850's revenue (13.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A003850's Return on Equity is forecast to be low in 3 years time (12.4%).

Boryung Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Price target decreased to ₩15,500

Price target increased to ₩17,500

Price target raised to ₩21,000

Price target raised to ₩21,000

Recent updates

Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

Full year 2023 earnings: EPS misses analyst expectations

Boryung Corporation, Annual General Meeting, Mar 26, 2024

Upcoming dividend of ₩100.00 per share at 0.9% yield

Boryung Corporation(KOSE:A003850) dropped from KOSPI 200 Index

Investor sentiment improves as stock rises 17%

New major risk - Revenue and earnings growth

Boryung Corporation Partners with Axiom Space and Aurelia Institute to Launch the "2023 Humans in Space" Program

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ₩100.00 per share

Less than half of directors are independent

Price target decreased to ₩15,500

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Upcoming dividend of ₩75.77 per share

Price target increased to ₩17,500

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ₩400 (vs ₩180 in 1Q 2020)

Investor sentiment deteriorated over the past week

A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Full year 2020 earnings released: EPS ₩554 (vs ₩698 in FY 2019)

Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Boryung Pharmaceutical Co., Ltd., Annual General Meeting, Mar 26, 2021

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

New 90-day high: ₩20,500

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Market pulls back on stock over the past week

Price target raised to ₩21,000

New 90-day high: ₩20,700

Market bids up stock over the past week

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Third quarter 2020 earnings released: EPS ₩168

New 90-day low: ₩14,750

New 90-day low: ₩15,250

Price target raised to ₩21,000

First half earnings released

New 90-day high - ₩17,550

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies